🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Accolade CEO sells over $6,000 in company stock

Published 05/09/2024, 15:14
ACCD
-

Rajeev Singh, the Chief Executive Officer of Accolade, Inc. (NASDAQ:ACCD), recently engaged in a transaction where he sold 1,527 shares of the company's common stock, according to a new SEC filing. The shares were sold at an average price of $4.224, totaling over $6,450.

The sale took place on September 4, 2024, and was part of a transaction to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs). It's important to note that this sale was mandatory to satisfy tax withholding and does not represent a discretionary trade by Singh.

Furthermore, the filing indicated that on September 3, 2024, Singh acquired 3,786 shares of Accolade's common stock as part of an RSU conversion, where each unit converted into one share. This acquisition did not involve any monetary transaction as it pertains to the conversion of RSUs into common stock.

After these transactions, Singh's direct ownership in the company stands at 787,024 shares of common stock. Additionally, Singh is associated with Avanti Holdings, LLC, which indirectly holds 651,619 shares, and he has voting and investment power over these securities.

Accolade, Inc., headquartered in Plymouth Meeting, PA, operates in the business services sector, providing a range of services to its clients. The transactions by the CEO are part of the regular financial activities executives undertake and are reported to the SEC for transparency and regulatory compliance.

Investors often monitor insider transactions as they can provide insights into the executives' perspective on the company's current valuation and future prospects. However, such transactions are common and can be influenced by a variety of personal financial considerations.

In other recent news, Accolade Inc. has been the subject of several analyst reports. Stifel, Canaccord Genuity, Needham, Truist Securities, and DA Davidson have all revised their price targets for the healthcare company, with varying ratings. This follows Accolade's first-quarter fiscal year 2025 results, which met expectations, and the subsequent adjustment of its revenue guidance for the year. The company has reported an 18% year-over-year revenue growth for the first quarter, totaling $110.5 million, but has revised its full-year revenue outlook for 2025 to between $460 million and $475 million, indicating a growth of 11% to 15%.

Accolade's management has chosen to prioritize profitability, leading to a decrease in expected growth from usage fees and a more conservative revenue forecast. Despite these changes, the company's EBITDA outlook for FY25 remains positive, ranging from $15 million to $20 million. While the company's long-term revenue goal of $1 billion has been delayed by approximately a year, analysts from firms such as Stifel and Needham maintain a positive outlook on Accolade's potential for growth and profitability. The company plans to discuss its long-term strategies at an upcoming Analyst Day, emphasizing sustainable growth while prioritizing profitability and bottom-line performance.

InvestingPro Insights

Accolade, Inc. (NASDAQ:ACCD) has been navigating a challenging market environment, as reflected in some key financial metrics. The company's market capitalization currently stands at $335.24 million, suggesting a moderate size within its sector. Despite the recent insider transactions by CEO Rajeev Singh, Accolade's stock price has experienced significant volatility, with a price that has fallen by nearly 69% over the past year. This may indicate broader market concerns or sector-specific headwinds affecting the company's valuation.

InvestingPro Tips highlight that Accolade's shareholder yield is high, which could be attractive to investors seeking companies that return value to shareholders. However, it is important to note that Accolade does not pay dividends, suggesting that shareholder yield may be coming from other sources such as stock buybacks or debt reduction. Additionally, analysts have recently revised their earnings expectations downwards for the upcoming period, which could be a signal to investors to temper their short-term expectations for the company's financial performance.

From a financial standpoint, Accolade operates with a moderate level of debt and its liquid assets exceed short-term obligations, indicating the company has maintained a degree of financial stability. Nonetheless, the company has not been profitable over the last twelve months, and analysts do not anticipate it will be profitable this year, which is an important consideration for investors looking at the company's long-term growth prospects.

For those interested in a deeper dive into Accolade's financial health and future outlook, InvestingPro offers additional insights and tips. Currently, there are over 10 additional InvestingPro Tips available, which can provide more nuanced guidance on the company's stock performance and what it might mean for potential investors.

For the latest expert analysis and detailed metrics on Accolade, Inc., visit https://www.investing.com/pro/ACCD.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.